Philips’ investors can ill-afford another jolt to their nerves
Published
Investors in the Dutch healthcare conglomerate had until this week been enjoying a restorative patch
Full ArticlePublished
Investors in the Dutch healthcare conglomerate had until this week been enjoying a restorative patch
Full Article